{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:01:15Z","timestamp":1785416475648,"version":"3.56.0"},"reference-count":49,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81702004"],"award-info":[{"award-number":["81702004"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"award":["81702004"],"award-info":[{"award-number":["81702004"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Air Force Medical University","award":["2022ZZXM044"],"award-info":[{"award-number":["2022ZZXM044"]}]},{"award":["2022ZZXM044"],"award-info":[{"award-number":["2022ZZXM044"]}],"id":[{"id":"https:\/\/ror.org\/00ms48f15","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Background: Rift Valley fever virus (RVFV) is a mosquito-borne zoonotic pathogen that has caused repeated epidemics across Africa and the Arabian Peninsula, posing a severe and growing threat to public health and livestock. Infection in ruminants causes high neonatal mortality and catastrophic abortion storms; human disease ranges from self-limiting febrile illness to hemorrhagic fever, encephalitis, and permanent blindness. No licensed human vaccines or specific antiviral therapeutics are available, creating an urgent unmet medical need. Methods: We systematically reviewed the peer-reviewed literature on RVFV neutralizing antibodies (NAbs), extracting and synthesizing data on antibody sources, epitope specificity, in vitro neutralizing potency, in vivo protective efficacy, and molecular mechanisms of action. Results: A growing body of work has identified potent NAbs from immunized rodents, rabbits, alpacas, non-human primates, and convalescent patients. These NAbs predominantly target the Gn and Gc envelope glycoproteins. Their mechanisms include blocking host receptor (LRP1) binding, preventing the pH-dependent conformational rearrangement of the Gn\u2013Gc complex, and directly inhibiting viral membrane fusion. Lead candidates, such as RVFV-268 and RVFV-140, achieve sub-nanogram neutralization and confer robust protection in rodent models against lethal challenge, aerosol exposure, and vertical transmission. Bispecific antibodies and combination strategies further enhance potency and the genetic barrier to viral escape. Conclusions: Substantial progress has illuminated the epitope landscape and neutralization mechanisms of RVFV, yielding promising clinical candidates. Translational challenges remain, including viral immune escape, antibody thermostability, and the need for rigorous preclinical evaluation. Future efforts should prioritize structure-guided engineering, rational antibody combinations, and testing in clinically predictive animal models.<\/jats:p>","DOI":"10.3390\/vaccines14060484","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T11:25:31Z","timestamp":1780399531000},"page":"484","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neutralizing Antibodies Against Rift Valley Fever Virus: Current Status and Advances"],"prefix":"10.3390","volume":"14","author":[{"given":"Binjie","family":"Wu","sequence":"first","affiliation":[{"name":"Student Brigade, School of Basic Medicine, Air Force Medical University: Fourth Military Medical University, Xi\u2019an 710032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Sun","sequence":"additional","affiliation":[{"name":"Student Brigade, School of Basic Medicine, Air Force Medical University: Fourth Military Medical University, Xi\u2019an 710032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[{"name":"Student Brigade, School of Basic Medicine, Air Force Medical University: Fourth Military Medical University, Xi\u2019an 710032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Wang","sequence":"additional","affiliation":[{"name":"Student Brigade, School of Basic Medicine, Air Force Medical University: Fourth Military Medical University, Xi\u2019an 710032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyang","family":"Han","sequence":"additional","affiliation":[{"name":"Student Brigade, School of Basic Medicine, Air Force Medical University: Fourth Military Medical University, Xi\u2019an 710032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Microbiology, School of Basic Medicine, Air Force Medical University: Fourth Military Medical University, Xi\u2019an 710032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3980-8547","authenticated-orcid":false,"given":"Wei","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Microbiology, School of Basic Medicine, Air Force Medical University: Fourth Military Medical University, Xi\u2019an 710032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/path.1700340418","article-title":"Enzootic hepatitis or rift valley fever. An undescribed virus disease of sheep cattle and man from east Africa","volume":"34","author":"Daubney","year":"1931","journal-title":"J. Pathol. Bacteriol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3181\/00379727-64-15803","article-title":"Human infection with Rift Valley fever virus and immunity twelve years after single attack","volume":"64","author":"Albert","year":"1947","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1086\/378747","article-title":"Rift Valley fever epidemic in Saudi Arabia: Epidemiological, clinical, and laboratory characteristics","volume":"37","author":"Madani","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1099\/jgv.0.001296","article-title":"Rift Valley fever: Biology and epidemiology","volume":"100","author":"Wright","year":"2019","journal-title":"J. Gen. Virol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1038\/emi.2016.136","article-title":"The first imported case of Rift Valley fever in China reveals a genetic reassortment of different viral lineages","volume":"6","author":"Liu","year":"2017","journal-title":"Emerg. Microbes Infect."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"6896","DOI":"10.1016\/j.cell.2024.09.008","article-title":"Rift Valley fever virus coordinates the assembly of a programmable E3 ligase to promote viral replication","volume":"187","author":"Li","year":"2024","journal-title":"Cell"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"180151","DOI":"10.1172\/jci.insight.180151","article-title":"Potent neutralizing human monoclonal antibodies protect from Rift Valley fever encephalitis","volume":"9","author":"Connors","year":"2024","journal-title":"JCI Insight"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Bales, J.M., Powell, D.S., Bethel, L.M., Reed, D.S., and Hartman, A.L. (2012). Choice of inbred rat strain impacts lethality and disease course after respiratory infection with Rift Valley Fever Virus. Front. Cell. Infect. Microbiol., 2.","DOI":"10.3389\/fcimb.2012.00105"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cll.2017.01.004","article-title":"Rift Valley Fever","volume":"7","author":"Hartman","year":"2017","journal-title":"Clin. Lab. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2174\/156652405774962263","article-title":"Rift Valley fever virus","volume":"5","author":"Flick","year":"2005","journal-title":"Curr. Mol. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"7181","DOI":"10.1016\/j.vaccine.2006.06.041","article-title":"Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever","volume":"24","author":"Wallace","year":"2006","journal-title":"Vaccine"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Lapa, D., Pauciullo, S., Ricci, I., Garbuglia, R.A., Maggi, F., Scicluna, M.T., and Tofani, S. (2024). Rift Valley Fever Virus: An Overview of the Current Status of Diagnostics. Biomedicines, 12.","DOI":"10.3390\/biomedicines12030540"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3390\/v3050493","article-title":"The Pathogenesis of Rift Valley Fever","volume":"3","author":"Ikegami","year":"2011","journal-title":"Viruses"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Huang, J., Adungo, F., Konongoi, S.L., Inoue, S., Zhan, L., Sang, R., Ashur, S., Kwallah, A.O., Mwau, M., and Morita, K. (2024). Monoclonal Antibodies for Rift Valley Fever Virus Nucleocapsid: Application in IgG\/IgM ELISA for Sero-Diagnosis. Pathogens, 13.","DOI":"10.3390\/pathogens13070582"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41421-021-00340-8","article-title":"Isolation of a panel of ultra-potent human antibodies neutralizing SARS-CoV-2 and viral variants of concern","volume":"7","author":"Gorchakov","year":"2021","journal-title":"Cell Discov."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"9682","DOI":"10.1038\/s41467-025-64687-2","article-title":"Neutralizing antibodies against Chikungunya virus and structural elucidation of their mechanism of action","volume":"16","author":"Han","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e2025642118","DOI":"10.1073\/pnas.2025642118","article-title":"Potent neutralization of Rift Valley fever virus by human monoclonal antibodies through fusion inhibition","volume":"118","author":"Chapman","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"10341","DOI":"10.1128\/JVI.01191-08","article-title":"Three-dimensional organization of Rift Valley fever virus revealed by cryoelectron tomography","volume":"82","author":"Freiberg","year":"2008","journal-title":"J. Virol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"5650","DOI":"10.1038\/s41467-023-41171-3","article-title":"Multifunctional human monoclonal antibody combination mediates protection against Rift Valley fever virus at low doses","volume":"14","author":"Chapman","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1016\/j.cell.2021.09.001","article-title":"Lrp1 is a host entry factor for Rift Valley fever virus","volume":"184","author":"Ganaie","year":"2021","journal-title":"Cell"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1007\/s00705-022-05516-5","article-title":"Recent changes to virus taxonomy ratified by the International Committee on Taxonomy of Viruses (2022)","volume":"167","author":"Walker","year":"2022","journal-title":"Arch. Virol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e42895","DOI":"10.1016\/j.heliyon.2025.e42895","article-title":"Inhibitory effects of bioactive molecules against nonstructural protein (NSs) of Rift Valley Fever Virus (RVFv): A molecular modeling study","volume":"11","author":"Dutt","year":"2025","journal-title":"Heliyon"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1099\/0022-1317-75-6-1345","article-title":"Rift Valley fever virus L segment: Correction of the sequence and possible functional role of newly identified regions conserved in RNA-dependent polymerases","volume":"75","author":"Muller","year":"1994","journal-title":"J. Gen. Virol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1126\/science.aal2712","article-title":"A glycerophospholipid-specific pocket in the RVFV class II fusion protein drives target membrane insertion","volume":"358","author":"Atkovska","year":"2017","journal-title":"Science"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"E7564","DOI":"10.1073\/pnas.1705176114","article-title":"Structures of phlebovirus glycoprotein Gn and identification of a neutralizing antibody epitope","volume":"114","author":"Wu","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"13642","DOI":"10.1128\/JVI.01973-12","article-title":"Acid-Activated Structural Reorganization of the Rift Valley Fever Virus Gc Fusion Protein","volume":"86","author":"Kortekaas","year":"2012","journal-title":"J. Virol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1073\/pnas.1217780110","article-title":"Crystal structure of glycoprotein C from Rift Valley fever virus","volume":"110","author":"Dessau","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0140-6736(83)91807-X","article-title":"Monoclonal antibodies to identify Zinga virus as Rift Valley Fever virus","volume":"321","author":"Meegan","year":"1983","journal-title":"Lancet"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1128\/jvi.58.2.263-270.1986","article-title":"Use of bacterial expression cloning to define the amino acid sequences of antigenic determinants on the G2 glycoprotein of Rift Valley fever virus","volume":"58","author":"Keegan","year":"1986","journal-title":"J. Virol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0923-2516(91)90069-F","article-title":"Antigenic analysis of Rift Valley fever virus isolates: Monoclonal antibodies distinguish between wild-type and neurotropic virus strains","volume":"142","author":"Besselar","year":"1991","journal-title":"Res. Virol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF01309641","article-title":"The synergistic neutralization of Rift Valley fever virus by monoclonal antibodies to the envelope glycoproteins","volume":"125","author":"Besselar","year":"1992","journal-title":"Arch. Virol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0923-2516(07)80002-1","article-title":"The effect of neutralizing monoclonal antibodies on early events in Rift Valley fever virus infectivity","volume":"145","author":"Besselaar","year":"1994","journal-title":"Res. Virol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Paesen, G.C., Chapman, N.S., Westover, J.B., McMillen, C.M., Kuzmina, N.A., Dews, E.A., Myers, L., Stass, R., Montgomery, J.M., and Bukreyev, A. (2026). Structural basis for recognition of Rift Valley fever virus Gn protein by a human neutralizing monoclonal antibody with a kappa light chain. PLoS Pathog., 22.","DOI":"10.1371\/journal.ppat.1013926"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Gutjahr, B., Keller, M., Rissmann, M., von Arnim, F., J\u00e4ckel, S., Reiche, S., Ulrich, R., Groschup, M.H., and Eiden, M. (2020). Two monoclonal antibodies against glycoprotein Gn protect mice from Rift Valley Fever challenge by cooperative effects. PLoS Neglected Trop. Dis., 14.","DOI":"10.1371\/journal.pntd.0008143"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1016\/j.celrep.2018.12.001","article-title":"A Protective Monoclonal Antibody Targets a Site of Vulnerability on the Surface of Rift Valley Fever Virus","volume":"25","author":"Brennan","year":"2018","journal-title":"Cell Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1038\/s41467-023-40187-z","article-title":"A highly potent human neutralizing antibody prevents vertical transmission of Rift Valley fever virus in a rat model","volume":"14","author":"McMillen","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e2514862122","DOI":"10.1073\/pnas.2514862122","article-title":"Cryo-EM structure of the Rift Valley fever virus envelope protein in complex with a potent neutralization antibody","volume":"122","author":"Zhang","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2623698","DOI":"10.1080\/22221751.2026.2623698","article-title":"Potent neutralization of Rift Valley fever virus mediated by monoclonal antibodies via concurrent inhibition of attachment and fusion","volume":"15","author":"Hao","year":"2026","journal-title":"Emerg. Microbes Infect."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/s41564-019-0411-z","article-title":"Neutralization mechanism of human monoclonal antibodies against Rift Valley fever virus","volume":"4","author":"Wang","year":"2019","journal-title":"Nat. Microbiol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Hao, M., Zhang, G., Zhang, S., Chen, Z., Chi, X., Dong, Y., Fan, P., Liu, Y., Chen, Y., and Song, X. (2020). Characterization of Two Neutralizing Antibodies against Rift Valley Fever Virus Gn Protein. Viruses, 12.","DOI":"10.3390\/v12030259"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Rosenfeld, R., Alcalay, R., Yahalom-Ronen, Y., Melamed, S., Sarusi-Portuguez, A., Noy-Porat, T., Israeli, O., Beth-Din, A., Blecher-Gonen, R., and Chitlaru, T. (2025). Efficient Identification of Monoclonal Antibodies Against Rift Valley Fever Virus Using High-Throughput Single Lymphocyte Transcriptomics of Immunized Mice. Antibodies, 14.","DOI":"10.3390\/antib14010012"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Zhao, C., Hao, M., Bian, T., Zhao, X., Chi, X., Chen, Z., Fu, G., Zhu, Z., Fang, T., and Yu, C. (2025). Screening of Neutralizing Antibodies Targeting Gc Protein of RVFV. Viruses, 17.","DOI":"10.3390\/v17040559"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1128\/JVI.02095-06","article-title":"Complete Genome Analysis of 33 Ecologically and Biologically Diverse Rift Valley Fever Virus Strains Reveals Widespread Virus Movement and Low Genetic Diversity due to Recent Common Ancestry","volume":"81","author":"Bird","year":"2007","journal-title":"J. Virol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.3201\/eid1712.111035","article-title":"Molecular Epidemiology of Rift Valley Fever Virus","volume":"17","author":"Grobbelaar","year":"2011","journal-title":"Emerg. Infect. Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12985-024-02613-6","article-title":"Standardization, validation, and comparative evaluation of a convenient surrogate recombinant vesicular stomatitis virus plaque reduction test for quantification of Hantaan orthohantavirus (HTNV) neutralizing antibodies","volume":"22","author":"Wei","year":"2025","journal-title":"Virol. J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF01321121","article-title":"Antibody-dependent enhancement of hantavirus infection in macrophage cell lines","volume":"122","author":"Yao","year":"1992","journal-title":"Arch. Virol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Sarker, A., Dhama, N., and Gupta, R.D. (2023). Dengue virus neutralizing antibody: A review of targets, cross-reactivity, and antibody-dependent enhancement. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1200195"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s42003-022-03207-0","article-title":"Antibody-dependent enhancement (ADE) of SARS-CoV-2 pseudoviral infection requires Fc\u03b3RIIB and virus-antibody complex with bivalent interaction","volume":"5","author":"Wang","year":"2022","journal-title":"Commun. Biol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e29628","DOI":"10.1002\/jmv.29628","article-title":"Antibody-dependent enhancement (ADE) of SARS-CoV-2 in patients exposed to MERS-CoV and SARS-CoV-2 antigens","volume":"96","author":"Thomas","year":"2024","journal-title":"J. Med. Virol."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/6\/484\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T04:12:27Z","timestamp":1780459947000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/6\/484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":49,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["vaccines14060484"],"URL":"https:\/\/doi.org\/10.3390\/vaccines14060484","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]}}}